These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
789 related articles for article (PubMed ID: 30489194)
1. Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a. Li C; Zhang S; Qiu T; Wang Y; Ricketts DM; Qi C Cancer Biol Ther; 2019; 20(4):413-422. PubMed ID: 30489194 [TBL] [Abstract][Full Text] [Related]
2. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis. He W; Zhang Y; Xia S Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353 [TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA NNT-AS1 promotes gastric cancer proliferation and invasion by regulating microRNA-363 expression. Wang X; Ren M; Li Y; Hu J; Lu G; Ma W; Guo D; Lu X; He S J Cell Biochem; 2019 Apr; 120(4):5704-5712. PubMed ID: 30324628 [TBL] [Abstract][Full Text] [Related]
5. LncRNA TMPO-AS1 serves as a ceRNA to promote osteosarcoma tumorigenesis by regulating miR-199a-5p/WNT7B axis. Cui H; Zhao J J Cell Biochem; 2020 Mar; 121(3):2284-2293. PubMed ID: 31680323 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of Long Non-Coding RNA NNT-AS1 Correlates with Tumor Progression and Poor Prognosis in Osteosarcoma. Ye H; Lin J; Yao X; Li Y; Lin X; Lu H Cell Physiol Biochem; 2018; 45(5):1904-1914. PubMed ID: 29518771 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway. Jia F; Zhang Z; Zhang X J Cell Biochem; 2019 Apr; 120(4):6420-6430. PubMed ID: 30484892 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR-195-5p. Yang C; Wu K; Wang S; Wei G J Cell Biochem; 2018 Jul; 119(7):5646-5656. PubMed ID: 29384226 [TBL] [Abstract][Full Text] [Related]
9. LncRNA FTX inhibition restrains osteosarcoma proliferation and migration via modulating miR-320a/TXNRD1. Huang S; Zhu X; Ke Y; Xiao D; Liang C; Chen J; Chang Y Cancer Biol Ther; 2020 Apr; 21(4):379-387. PubMed ID: 31920141 [TBL] [Abstract][Full Text] [Related]
10. The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145. Zhou Y; Feng D; Gu X; Gao A; Liu Y Anticancer Drugs; 2021 Feb; 32(2):168-177. PubMed ID: 32826416 [TBL] [Abstract][Full Text] [Related]
11. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142. Zhang L; Zhao G; Ji S; Yuan Q; Zhou H Med Sci Monit; 2020 Mar; 26():e921594. PubMed ID: 32155139 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA (LncRNA) MRPL23-AS1 promotes tumor progression and carcinogenesis in osteosarcoma by activating Wnt/β-catenin signaling via inhibiting microRNA miR-30b and upregulating myosin heavy chain 9 (MYH9). Zhang H; Liu S; Tang L; Ge J; Lu X Bioengineered; 2021 Dec; 12(1):162-171. PubMed ID: 33356805 [TBL] [Abstract][Full Text] [Related]
13. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p. Wang D; Zheng Y Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561 [TBL] [Abstract][Full Text] [Related]
14. Silencing of long noncoding RNA SBF2-AS1 inhibits proliferation, migration and invasion and contributes to apoptosis in osteosarcoma cells by upregulating microRNA-30a to suppress FOXA1 expression. Dai JH; Huang WZ; Li C; Deng J; Lin SJ; Luo J Cell Cycle; 2019 Oct; 18(20):2727-2741. PubMed ID: 31432728 [No Abstract] [Full Text] [Related]
15. LncRNA NNT-AS1 regulates the progression of lung cancer through the NNT-AS1/miR-3666/E2F2 axis. Huang JW; Luo XY; Li ZH; Lang BP Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):238-248. PubMed ID: 31957837 [TBL] [Abstract][Full Text] [Related]
16. lncRNA nuclear-enriched abundant transcript 1 promotes cell proliferation and invasion by targeting miR-186-5p/HIF-1α in osteosarcoma. Tan H; Zhao L J Cell Biochem; 2019 Apr; 120(4):6502-6514. PubMed ID: 30485482 [TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA Li S; Liu F; Pei Y; Wang W; Zheng K; Zhang X Aging (Albany NY); 2019 Sep; 11(18):7678-7693. PubMed ID: 31525734 [TBL] [Abstract][Full Text] [Related]
18. LncRNA TTN-AS1 promotes the progression of cholangiocarcinoma via the miR-320a/neuropilin-1 axis. Zhu H; Zhai B; He C; Li Z; Gao H; Niu Z; Jiang X; Lu J; Sun X Cell Death Dis; 2020 Aug; 11(8):637. PubMed ID: 32801339 [TBL] [Abstract][Full Text] [Related]
19. LncRNA ROR1-AS1 accelerates osteosarcoma invasion and proliferation through modulating miR-504. Wu X; Yan L; Liu Y; Shang L Aging (Albany NY); 2020 Dec; 13(1):219-227. PubMed ID: 33401251 [TBL] [Abstract][Full Text] [Related]
20. LncRNA FOXD2-AS1 knockdown inhibits the resistance of human osteosarcoma cells to cisplatin by inhibiting miR-143 expression. Zhang QQ; Xu SL; Ding C; Ma CC; Yuan TS; Hua CC; Wang XH Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):678-686. PubMed ID: 33577022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]